Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
CASM > SEC Filings for CASM > Form 8-K on 16-Jul-2013All Recent SEC Filings

Show all filings for CAS MEDICAL SYSTEMS INC | Request a Trial to NEW EDGAR Online Pro



Results of Operations and Financial Condition, Regulation FD Disclosure,

Item 2.02. Results of Operations and Financial Condition.

On July 16, 2013, CAS Medical Systems, Inc. (the "Company") filed a Preliminary Prospectus Supplement pursuant to Rule 424(b)(5) of the Securities Act of 1933, as amended (the "Securities Act"), which contained the following information on page S-2 thereof:

We have completed our second fiscal quarter ended June 30, 2013. Although we have not yet finalized and announced our consolidated financial results for the second quarter of 2013, our preliminary financial data reflect revenues of approximately $5.0 million for the quarter, consisting of $2.2 million from sales of Tissue Oximetry Monitoring products, an increase of approximately 15% from the same period in the prior year, and $2.8 million from sales of our Traditional Monitoring products, a decrease of approximately 13% from the same period in the prior year. We expect to announce a net loss for the quarter ended June 30, 2013.

Item 7.01. Regulation FD Disclosure.

On July 16, 2013, the Company issued a press release announcing a proposed underwritten public offering of its common stock. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The Company is furnishing the information in this Current Report on Form 8-K to comply with Regulation FD. Such information, including Exhibit 99.1, shall not be deemed "filed" for any purpose, including for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section. The information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act, regardless of any general incorporation language in such filings.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Description

99.1 Press Release dated July 16, 2013

  Add CASM to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for CASM - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.